Last reviewed · How we verify
Sanaria Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
4 Phase 2
3 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Infectious Diseases · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Beijing Minhai Biotechnology Co., Ltd · 1 shared drug class
- Bharat Biotech International Limited · 1 shared drug class
- BioNTech · 1 shared drug class
- Boryung Pharmaceutical Co., Ltd · 1 shared drug class
- CanSino Biologics Inc. · 1 shared drug class
- Centre for Infectious Disease Research in Zambia · 1 shared drug class
- Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno · 1 shared drug class
- Arcturus Therapeutics, Inc. · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Sanaria Inc.:
- Sanaria Inc. pipeline updates — RSS
- Sanaria Inc. pipeline updates — Atom
- Sanaria Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Sanaria Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sanaria-inc. Accessed 2026-06-10.